Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sex-related differences in amyotrophic lateral sclerosis: A 2-[18F]FDG-PET study.
Canosa A, Martino A, Manera U, Giuliani A, Vasta R, Palumbo F, Grassano M, Morbelli SD, Pardini M, Chiaravalloti A, Schillaci O, Leenders KL, Kogan RV, Polverari G, Zocco G, Pede FD, Mattei F, Cabras S, Matteoni E, Moglia C, Calvo A, Chiò A, Pagani M. Canosa A, et al. Among authors: manera u. Eur J Neurol. 2025 Jan;32(1):e16588. doi: 10.1111/ene.16588. Eur J Neurol. 2025. PMID: 39655539 Free PMC article.
Predicting clinical events characterizing the progression of amyotrophic lateral sclerosis via machine learning approaches using routine visits data: a feasibility study.
Guazzo A, Atzeni M, Idi E, Trescato I, Tavazzi E, Longato E, Manera U, Chió A, Gromicho M, Alves I, de Carvalho M, Vettoretti M, Di Camillo B. Guazzo A, et al. Among authors: manera u. BMC Med Inform Decis Mak. 2024 Oct 29;24(Suppl 4):318. doi: 10.1186/s12911-024-02719-5. BMC Med Inform Decis Mak. 2024. PMID: 39472842 Free PMC article.
Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data.
Saez-Atienzar S, Souza CDS, Chia R, Beal SN, Lorenzini I, Huang R, Levy J, Burciu C, Ding J, Gibbs JR, Jones A, Dewan R, Pensato V, Peverelli S, Corrado L, van Vugt JJFA, van Rheenen W, Tunca C, Bayraktar E, Xia M; International ALS Genomics Consortium; ITALSGEN Consortium; SLAGEN Consortium; Project MinE ALS Sequencing Consortium; Iacoangeli A, Shatunov A, Tiloca C, Ticozzi N, Verde F, Mazzini L, Kenna K, Al Khleifat A, Opie-Martin S, Raggi F, Filosto M, Piccinelli SC, Padovani A, Gagliardi S, Inghilleri M, Ferlini A, Vasta R, Calvo A, Moglia C, Canosa A, Manera U, Grassano M, Mandrioli J, Mora G, Lunetta C, Tanel R, Trojsi F, Cardinali P, Gallone S, Brunetti M, Galimberti D, Serpente M, Fenoglio C, Scarpini E, Comi GP, Corti S, Del Bo R, Ceroni M, Pinter GL, Taroni F, Bella ED, Bersano E, Curtis CJ, Lee SH, Chung R, Patel H, Morrison KE, Cooper-Knock J, Shaw PJ, Breen G, Dobson RJB, Dalgard CL; American Genome Center; Scholz SW, Al-Chalabi A, van den Berg LH, McLaughlin R, Hardiman O, Cereda C, Sorarù G, D'Alfonso S, Chandran S, Pal S, Ratti A, Gellera C, Johnson K, Doucet-O'Hare T, Pasternack N, Wang T, Nath A, Siciliano G, Silani V, Başak AN, Veldink JH, Camu W, Glass J… See abstract for full author list ➔ Saez-Atienzar S, et al. Among authors: manera u. Cell Genom. 2024 Nov 13;4(11):100679. doi: 10.1016/j.xgen.2024.100679. Epub 2024 Oct 21. Cell Genom. 2024. PMID: 39437787 Free PMC article.
Reply to "Comprehensive Analysis of Sex Differences in Amyotrophic Lateral Sclerosis Prognosis and Disease Progression".
Grassano M, Moglia C, Palumbo F, Koumantakis E, Cugnasco P, Callegaro S, Canosa A, Manera U, Vasta R, De Mattei F, Matteoni E, Fuda G, Salamone P, Marchese G, Casale F, De Marchi F, Mazzini L, Mora G, Calvo A, Chiò A. Grassano M, et al. Among authors: manera u. Ann Neurol. 2024 Nov;96(5):1029. doi: 10.1002/ana.27095. Epub 2024 Oct 9. Ann Neurol. 2024. PMID: 39381976 No abstract available.
Intermediate HTT CAG repeats worsen disease severity in amyotrophic lateral sclerosis.
Grassano M, Canosa A, D'Alfonso S, Corrado L, Brodini G, Koumantakis E, Cugnasco P, Manera U, Vasta R, Palumbo F, Mazzini L, Gallone S, Moglia C, Dewan R, Chia R, Ding J, Dalgard C, Gibbs RJ, Scholz S, Calvo A, Traynor B, Chio A. Grassano M, et al. Among authors: manera u. J Neurol Neurosurg Psychiatry. 2024 Dec 16;96(1):100-102. doi: 10.1136/jnnp-2024-333998. J Neurol Neurosurg Psychiatry. 2024. PMID: 39242198 Free article. No abstract available.
REVEALS-a longitudinal cohort study of multifaceted respiratory assessment in ALS.
Rooney J, Murray D, Meldrum D, Al-Chalabi A, Bunte T, Chiwera T, Choudhury M, Chio A, Fenton L, Fortune J, Maidment L, Manera U, McDermott CJ, Meyjes M, Tattersall R, Torrieri MC, Van Damme P, Vanderlinden E, Wood C, van den Berg LH, Hardiman O. Rooney J, et al. Among authors: manera u. Amyotroph Lateral Scler Frontotemporal Degener. 2024 Nov;25(7-8):661-671. doi: 10.1080/21678421.2024.2359556. Epub 2024 Jun 6. Amyotroph Lateral Scler Frontotemporal Degener. 2024. PMID: 38845371 Free PMC article.
Disentangling the relationship between social cognition, executive functions and behaviour changes in amyotrophic lateral sclerosis.
Palumbo F, Iazzolino B, Callegaro S, Canosa A, Manera U, Vasta R, Grassano M, Matteoni E, Cabras S, Pellegrino G, Salamone P, Peotta L, Casale F, Fuda G, Moglia C, Chio A, Calvo A. Palumbo F, et al. Among authors: manera u. J Neurol Neurosurg Psychiatry. 2024 Jul 15;95(8):722-729. doi: 10.1136/jnnp-2023-332700. J Neurol Neurosurg Psychiatry. 2024. PMID: 38839275 Free article.
Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
Benatar M, Hansen T, Rom D, Geist MA, Blaettler T, Camu W, Kuzma-Kozakiewicz M, van den Berg LH, Morales RJ, Chio A, Andersen PM, Pradat PF, Lange D, Van Damme P, Mora G, Grudniak M, Elliott M, Petri S, Olney N, Ladha S, Goyal NA, Meyer T, Hanna MG, Quinn C, Genge A, Zinman L, Jabari D, Shoesmith C, Ludolph AC, Neuwirth C, Nations S, Shefner JM, Turner MR, Wuu J, Bennett R, Dang H, Sundgreen C; ORARIALS-01 trial team. Benatar M, et al. Lancet Neurol. 2024 Jul;23(7):687-699. doi: 10.1016/S1474-4422(24)00134-0. Epub 2024 May 20. Lancet Neurol. 2024. PMID: 38782015 Clinical Trial.
117 results